Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Ju-Yeon Cho, Soon Sun Kim, Young-Sun Lee, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim

Clin Mol Hepatol. 2020;26(3):243-250. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0111

View: 7029 Download: 230 Web of Science: 8 Crossref: 7

Hyun Hee Chu, Woo Sung Moon

Clin Mol Hepatol. 2013;19(2):185-189. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.185

View: 7232 Download: 57 Crossref: 4

Woo Young Shin, M.D., Kyung-Suk Suh, M.D. Taehoon Kim, M.D. Young Min Jeon, M.D. Nam-Joon Yi, M.D. Kuhn Uk Lee, M.D.

Clin Mol Hepatol. 2010;16(2):168-175. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.168

View: 4421 Download: 19 Crossref: 3

1 |

Viewed By 5394	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5358	MAFLD: How is it different from NAFLD?
Viewed By 5243	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3924	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3897	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search